Loading…
$6.8B
Market Cap
102.3
P/E
2.15
PEG
29.9%
ROCE
8.7%
ROE
0.84
D/E
25.8%
OPM
-31.4%
% from 52W High
78
α RS
🔍 CAMT is showing a high-conviction setup because it matches 6 of 37 tracked screener presets, RS Rating is 78, and an ECS of 59.4 last quarter. Net: Broad signal stack, not a recommendation. ? Conviction RS Rating ECS
Sources
Conviction 6/37 · RS Rating 78 · ECS 59.4
⚖️ Compare 🔒 Generate Report 🔒 Research Packet 📚 Guides
🌏 Global Investor Returns
Currency-adjusted total returns for CAMT including FX impact
🌏
Click 🌏 Returns tab to load data
📈 Price History
Ratio Health
Excellent
Good
Average
Poor
By Category
📊 Sector Averages
About

Camtek Ltd., together with its subsidiaries, develops, manufactures, and sells inspection and metrology equipment for semiconductor industry in the United States, China, Korea, Europe, and the Asia Pacific.

Key Ratios Snapshot
📈 Growth Pattern
📊 Quick Scorecard
Loading…
⭐ Superinvestors Holding CAMT
View All Superinvestors →
Manager Shares Value % of Fund Period
Cathie Wood ARK Investment Management 15.4K $2.3M 0.02% Mar 2026

SEC Form 13F data. 45-day lag from quarter end.

🔒
Premium Feature
AI-generated 10-section company profile — business model, financials, strengths, risks & management quality
Upgrade to Premium
Already a member? Log in
📐
3-Statement Financial Model
Bear / Base / Bull projections · DCF fair value · Reverse-DCF
Open Model →
🎙 Management Tone Confident Specific → Stable 4 quarters Full tone analysis in Intelligence →
📊 MIXED Camtek Q1 revenue $121.7M, guides Q2 $129-131M; $260M HBM orders for 2026-2027.
Revenue & Profitability
Q1 2026 revenue was $121.7 million, slightly above guidance. Gross profit was $62 million (51% margin). Operating income was $31.1 million (25.5% margin), and net income was $35.3 million ($0.70 per diluted share), compared to $38.7 million ($0.79) in Q1 2025. Operating expenses rose to $30.9 million due to R&D and sales investments and a weaker USD against the shekel.
Outlook
Management sees robust demand driven by AI, HBM, and advanced packaging, with an 'unprecedented' start to 2026 in orders. They expect Q2 revenue of $129-131 million and a surge in the second half, with revenues over 25% higher than the first half. The OSAT segment is undergoing significant investment in advanced packaging for AI, and Camtek expects to be a major beneficiary.
Growth Drivers
Key growth levers include $260 million in orders and forecasts from two HBM manufacturers for 3D metrology and 2D inspection steps for 2026-2027, plus additional incremental business from HPC players. The company is gaining market share in 2D inspection and 3D metrology, with new products (Eagle G5 and Hawk) expected to double revenue in 2026. OSAT capacity expansion and AI-driven demand are also driving growth.
Balance Sheet & CapEx
Not discussed in this earnings call beyond inventory management and the acquisition of Visual Layer (closed). Inventory was $116.7 million, and the company plans to increase it to support strong growth. No specific CapEx guidance was provided.
Margins
Gross margin was 51% in Q1, similar to the prior quarter. Management expects gross margin to improve in the second half due to strong revenue and the contribution of Hawk and Eagle G5 (which are doubling in revenue). Operating margin was 25.5% in Q1 but is expected to return to around 30% in the second half as revenue scales.
Key Risks
Management noted the geopolitical situation in Israel but stated operations are unaffected. Component pricing increases pose a potential headwind to gross margins, though cost reductions are being implemented. Competitive pressure in China, especially from local players at the low end, is a risk. No other explicit risks were flagged in the call.
Generated by AI · Q1 2026 results · Not investment advice
🔒
Free Account Required

Create a free Finmagine account to access Finmagine™ Scorecard.

See how this company scores across 5 dimensions — Financial Health, Growth Prospects, Competitive Position, Management Quality, and Valuation — powered by 30+ computed ratios.

Create Free AccountLog In
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Ask AI.

Get 25 expert AI analysis templates — Business KPIs, Comprehensive, Forensic Governance, Peer Comparison, Risk-Reward, Full Research Report, IPO Decoder, Red Flag Detector, and more — ready to paste into ChatGPT, Claude, Gemini, or Perplexity.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Peer Comparison.

Compare this company side-by-side against its sector peers with financial metrics, ratio benchmarking, and relative performance across all key dimensions.

Upgrade to PremiumCreate Free Account
✓ 📞 Earnings Call Transcripts (5 quarters) submit a missing quarter
🔍
🔎 See cross-company document search → ?
📞 Earnings Call Transcripts (5)
Q2 2026 Q2 2026 2026-08-10
Record Q2 revenue and strong order intake signal robust growth, with advanced packaging and AI-related applications driving performance. Gross and operating margins are set to improve, and visibility into 2027 is strong, supported by new product launches and expanding market opportunities.
Q1 2026 Q1 2026 2026-05-12
Q1 2026 saw revenue of $121.7M with strong AI and advanced packaging demand, record orders, and robust outlook for 2026–2027. Visual Layer acquisition boosts AI capabilities, and H2 2026 revenue is expected to surge over 25% from H1.
Q4 2025 Q4 2025 2026-02-18
Record Q4 and full-year results driven by AI and advanced packaging, with strong cash flow and a robust order pipeline. Double-digit growth is expected in 2026, with margin improvements and increased market share anticipated in the second half.
Q3 2025 Q3 2025 2025-11-10
Record Q3 revenue and profitability driven by strong HPC and advanced packaging demand, with new products poised to boost margins and market share. 2026 growth expected, especially in the second half, as AI and data center investments accelerate.
Q2 2025 Q2 2025 2025-08-05
Record Q2 revenue and profit driven by strong HPC and advanced packaging demand, with new Hawk and Eagle G5 systems gaining traction. Positive momentum and robust order pipeline support continued growth into Q3 and beyond.
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Catalyst Timeline.

Every result, order win, insider trade, ECS update, earnings-call, and SEC announcement for this company — in one chronological lane.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Full Report.

Read the complete Finmagine™ investment research report — comprehensive fundamental analysis, business model assessment, competitive positioning, and investment recommendation.

Upgrade to PremiumCreate Free Account

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯
Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.
📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

Financial Model
Projections are built from each company's audited annual financials (Income Statement, Balance Sheet, Cash Flow) over the last 5 fiscal years. Forward assumptions — revenue growth %, EBITDA margin, D&A (USD millions), interest expense, tax rate, and capex — are AI-generated using historical context and refreshed twice a year: after the December results season and after the September/Q4 results season.

DCF Valuation
Fair Value = Σ(FCFt / (1+WACC)t) + Terminal Value. Terminal Value uses the Gordon Growth Model: FCF5 × (1+g) / (WACC−g). Default WACC: 10% (US risk-free ~4.5%, equity risk premium ~5.5%). Default terminal growth: 3% (long-run US nominal GDP proxy).

CAGR Tracker
Expected 5-year CAGR = (DCF Fair Value / Current Price)1/5 − 1. Assumes fair value is reached in exactly 5 years — a mechanical estimate only.

Data Sources & Limitations
Financial statements sourced from public filings. Prices updated daily. Forward assumptions are AI-generated. All monetary values in USD millions. Non-US ADR companies may have currency conversion inaccuracies. Models are point-in-time and do not update intra-quarter or account for M&A, macro shocks, or extraordinary items.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.